- Home
- TIMB vs COEP Comparison
TIMB vs COEP Comparison
Compare TIMB & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIMB
- COEP
- Stock Information
- Founded
- TIMB 1998
- COEP 2017
- Country
- TIMB Brazil
- COEP United States
- Employees
- TIMB N/A
- COEP N/A
- Industry
- TIMB Telecommunications Equipment
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TIMB Telecommunications
- COEP Health Care
- Exchange
- TIMB Nasdaq
- COEP Nasdaq
- Market Cap
- TIMB 94.1M
- COEP 86.0M
- IPO Year
- TIMB 1998
- COEP N/A
- Fundamental
- Price
- TIMB $21.39
- COEP $16.31
- Analyst Decision
- TIMB Hold
- COEP
- Analyst Count
- TIMB 4
- COEP 0
- Target Price
- TIMB $20.50
- COEP N/A
- AVG Volume (30 Days)
- TIMB 263.3K
- COEP 64.3K
- Earning Date
- TIMB 11-04-2025
- COEP 11-12-2025
- Dividend Yield
- TIMB 6.53%
- COEP N/A
- EPS Growth
- TIMB 16.41
- COEP N/A
- EPS
- TIMB 0.27
- COEP N/A
- Revenue
- TIMB $4,779,664,328.00
- COEP $263,555.00
- Revenue This Year
- TIMB $8.08
- COEP N/A
- Revenue Next Year
- TIMB $5.29
- COEP N/A
- P/E Ratio
- TIMB $15.57
- COEP N/A
- Revenue Growth
- TIMB 5.32
- COEP N/A
- 52 Week Low
- TIMB $11.32
- COEP $2.31
- 52 Week High
- TIMB $22.47
- COEP $19.19
- Technical
- Relative Strength Index (RSI)
- TIMB N/A
- COEP 60.64
- Support Level
- TIMB N/A
- COEP $16.50
- Resistance Level
- TIMB N/A
- COEP $18.15
- Average True Range (ATR)
- TIMB 0.00
- COEP 1.58
- MACD
- TIMB 0.00
- COEP 0.02
- Stochastic Oscillator
- TIMB 0.00
- COEP 65.84
About TIMB TIM S.A. (Each representing 5)
TIM, which is 67%-owned by Telecom Italia, is the third largest wireless carrier in Brazil, with 62 million subscribers, equal to about 24% of the market. The firm also owns 49% of I-Systems, an infrastructure partnership that is expanding its network footprint across Brazil. I-Systems can provide broadband service to about 9 million locations, equal to 10%-15% of the country. TIM leases capacity on the venture's network to serve retail broadband customers under the UltraFibra brand. TIM also resells fiber network access from other providers, including Oi's former infrastructure business V.tal. In total, TIM claims it can offer fixed broadband service to about 16 million locations.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.